Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT06278051
Eligibility Criteria:
Inclusion Criteria:At index date, which is the date of first prescription of rivaroxaban or of warfarin during the study period
* Age less than 18 years
* Diagnosis of VTE at any point before and including the index date
* Receiving a prescription/dispensation of rivaroxaban or warfarin
Exclusion Criteria:
* none
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Months
Maximum Age:
18 Years
Study:
NCT06278051
Study Brief:
Protocol Section:
NCT06278051